AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 11%
#552 out of 5269 analysts
Average Return
+10.43%
Win Rate
51%77 out of 152
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | +381.97% | $16.42 | $79.14 | 2025-08-07 - 2026-05-06 | Buy |
Uniqure NvQURE | +263.97% | $7.16 | $26.06 | 2024-11-05 - 2025-11-05 | Buy |
Arrowhead Pharmaceuticals IncARWR | +233.09% | $18.89 | $62.92 | 2025-02-10 - 2026-02-10 | Buy |
Ionis Pharmaceuticals IncIONS | +154.34% | $32.69 | $83.15 | 2025-02-19 - 2026-02-19 | Buy |
Allogene Therapeutics IncALLO | +142.39% | $0.95 | $2.31 | 2025-05-13 - 2026-05-06 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 13 | Hold | $66.00 | +20.88% | Reiterates | 2 days ago |
Moderna IncMRNA | 20 | Hold | $38.00 | -22.12% | Maintains | 3 days ago |
Alnylam Pharmaceuticals IncALNY | 29 | Buy | $445.00 | +46.86% | Maintains | 6 days ago |
Ionis Pharmaceuticals IncIONS | 12 | Buy | $100.00 | +32.54% | Maintains | 7 days ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $100.00 | +46.86% | Initiates Coverage On | a month ago |
Uniqure NvQURE | 8 | Buy | $35.00 | +53.37% | Upgrades | 2 months ago |
Intellia Therapeutics IncNTLA | 8 | Hold | $15.00 | +8.30% | Maintains | 2 months ago |
Ascendis Pharma AASND | 5 | Buy | $275.00 | +16.57% | Maintains | 2 months ago |
Argenx SeARGX | 4 | Buy | $890.00 | +10.21% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 8 | Hold | $26.00 | -19.60% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 11 | Buy | $80.00 | +1.09% | Maintains | 5 months ago |
Wave Life Sciences LtdWVE | 6 | Buy | $27.00 | +270.37% | Upgrades | 5 months ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $10.00 | +40.65% | Maintains | 5 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Hold | $28.00 | +3.78% | Downgrades | 6 months ago |
Korro Bio IncKRRO | 8 | Hold | $8.00 | -40.03% | Downgrades | 6 months ago |
Crispr Therapeutics AgCRSP | 14 | Hold | $50.00 | -9.22% | Maintains | 6 months ago |
Regenxbio IncRGNX | 10 | Buy | $19.00 | +85.91% | Maintains | 6 months ago |
Dyne Therapeutics IncDYN | 4 | Buy | $30.00 | +59.24% | Maintains | 6 months ago |
Avidity Biosciences IncRNAM | 3 | Hold | $72.00 | +388.14% | Downgrades | 6 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | -8.26% | Maintains | a year ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +332.90% | Reiterates | a year ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -56.23% | Maintains | a year ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | N/A | Maintains | a year ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | N/A | Reiterates | a year ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | N/A | Maintains | a year ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | N/A | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | N/A | Maintains | a year ago |
Slb LimitedSLB | 1 | Buy | $57.00 | N/A | Reiterates | a year ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | N/A | Maintains | a year ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | N/A | Reiterates | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | N/A | Reiterates | 2 years ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | 2 years ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.